Pennant Group to Participate in the 2026 Stephens Annual Investment Conference
C&F Financial Corporation Announces Increase in Quarterly Dividend
Oncolytics Biotech® Announces Clinical Supply Agreement to Evaluate Pelareorep in Combination with LOQTORZI® (toripalimab-tpzi) in SCAC
XPENG Announces UK Pricing for New L03 and Flagship G9L, Starting from £32,990 and £64,990
Klépierre: Disclosure of transactions in own shares from November 6 to 13, 2026
